2021
DOI: 10.24287/1726-1708-2020-19-4suppl-18-29
|View full text |Cite
|
Sign up to set email alerts
|

Immunoglobulin replacement therapy in patients with primary immunodeficiency diseases in Russia

Abstract: According to the data from Russian primary immunodeficiencies (PID) registry 71% of registered patients were treated with immunoglobulins (IG). Regular immunoglobulin substitutions were reported in 90% of patients with primary antibody deficiencies (PAD), 86% -with syndromic PID and 91% of patients with combined T and B cell defects. The study was supported by Academic

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 17 publications
0
0
0
Order By: Relevance